Chen Jinzhu PhD 4
4 · Oncternal Therapeutics, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
Chen Jinzhu PhD
Director
Transactions
- Award
Stock Options
2022-06-16+25,000→ 25,000 totalExercise: $1.08Exp: 2032-06-16→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.